Characterization of the Metabolic Fate of an Oral Arginine Form

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2013

Conditions
OverweightHypertriglyceridemic Waist
Interventions
DIETARY_SUPPLEMENT

A form Arginine

3 capsules containing 0.5g of A form of L-arginine (1.5g) 3 times daily (4.5g per day) for 1 week

DIETARY_SUPPLEMENT

B form Arginine

3 capsules containing 0.5g of B form of L-arginine (1.5g) 3 times daily (4.5g per day) for 1 week

Trial Locations (1)

93000

Centre de Recherche sur Volontaires (CRV), Hospital Avicenne, Bobigny

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Institut de Recherche Pierre Fabre

OTHER

collaborator

Hospital Avicenne

OTHER

collaborator

Adeprina

OTHER

lead

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

OTHER

NCT02352740 - Characterization of the Metabolic Fate of an Oral Arginine Form | Biotech Hunter | Biotech Hunter